| abstract |
In accordance with the present invention there is provided a pharmaceutical combination useful for the treatment of cancer comprising at least one activ e compound of formula (I): and at least one further therapeutic agent chosen from a nucleoside analogue and/or a chemotherapeutic agents; and, a method o f treating a patient having cancer comprising at least one active compound of formula (I), as defined above, and at least one further therapeutic agent chosen from a nucleoside analogue and/or a chemotherapeutic agents. |